The BIG Difference
A Global Leader In Retained Life Science Search
MARKET EXPERTISE
Maximizing Shareholder Value
BIOTECHNOLOGY
Your Partner In Executive and Board Search
PHARMACEUTICAL
Your Partner In Executive and Board Search
MEDICAL DEVICE
Your Partner In Executive and Board Search
CONTRACT SERVICES
Your Partner In Executive and Board Search
LETTER FROM THE CHAIRMAN
OVERVIEW
Blaise Group International has emerged to be a leading retained human capital search and strategic services firm exclusively servicing Life Science organizations on a global basis.
This unique fusion of executive through board level search and strategic services has enabled Blaise Group International to partner with a diverse array of organizations. Many clients are considered to be some of the world’s largest and well-known pharmaceutical and medical device companies, prestigious academic and not-for-profit organizations, middle market and emerging biotechnology, pure-play device and diagnostic companies.
Blaise Group International recognizes that each Life Science market sector, every organization, every technology and product carries succinctly different challenges. To best serve its clients, Blaise Group International established the following executive through board level niche market recruiting divisions:
This niche market organizational structure is quite unique to the human capital industry and has proven to be a very effective tool and a major competitive advantage. Each search division has unparalleled expertise within that industry niche market. Blaise Group International’s core competency is centered on the foundation of truly knowing its client, their needs, their market sector and the top performers and key decision makers thereof. As a direct result, Blaise Group International is able to provide the highest level of service and the very best of human capital solutions in Life Sciences.
MARKET EXPERTISE
Blaise Group International is positioned to be the preeminent human capital search and strategic services leader for the Life Sciences. Each search division has world-class niche market recruiting expertise, pre-established relationships with the top performers and key decision makers therein, have an excellent understanding of its client’s competitive landscape and a considerable proven track record of success.
BIOTECHNOLOGY DIVISION
The Biotechnology division encompasses organizations within niche markets that have biologic, synthetic and small molecule pharmaceuticals, therapeutics, molecular diagnostics, delivery system technologies and combination products that cover a diversity of disease and clinical indications.
Improving Treatments
Finding Cures and Saving Lives
PHARMACEUTICAL DIVISION
Blaise Group International’s Pharmaceutical Division encompasses organizations that produce medicinal products. BGI collaborates with proven leaders that have driven and continue to drive ideas from early-stage discovery, through drug development, and into the market. BGI’s Pharmaceutical Division clients have a track record of success with regulatory bodies, i.e. U.S. Food and Drug Administration (FDA), Medicines and Healthcare products Regulatory Agency (MHRA), and the European Medicines Agency (EMA), etc.
Blaise Group International appreciates the complexities and challenges of all things pharma – from prescription therapeutics to prophylactics, orphan drugs and over-the-counter (OTC) consumer products. With over 20 years of high-quality continuity, we support our clients, both large and small, in fulfilling medical innovation, expanding market share, and exceeding the requirements of shareholders, scientists, and mostly, the patients.
Global Reach
MEDICAL DEVICE DIVISION
Blaise Group International’s executive through board level recruiting expertise in this division completely encompasses the full spectrum of the medical device niche market. To include but not limited to partnering with organizations that have implantable, biologic, novel device and combination drug/device technologies that comprise of multiple medical needs and clinical indications.
Building Exceptional Teams
Driving Innovation
CONTRACT SERVICES DIVISION
Blaise Group International’s Contract Service Division supports our clients in maneuvering their competitive landscapes. We help them grow and bring more value to our client’s shareholders and their other investors. With over 20 years of niche focus, BGI has helped life science organizations strategize effectively to meet investor timelines while also establishing policy and ensuring compliance and on-site accountability.
As organizations scale and mature, they must continue to fuel growth and create a sustainable value. We specialize in building and integrating business models that bring out the most out of current enterprise capabilities. Blaise Group International is the global leader in securing partnerships with the most respected professionals in the life sciences field that can, along with due diligence on our end, produce navigable and rewarding ideas within the complex Biotechnological, Pharmaceutical, and Medical Device Divisions.
Working & Partnering Together
We are leaders in this life science revolution
Thank you for your interest in Blaise Group International. We are a global leader in the Life Science human capital solutions and strategic services industry. We focus on executive through board level search. Our recruiting divisions are uniquely structured by niche market expertise. Our strategic services division assists our clients with very specific corporate business development and organizational development goals.
We have a dynamic, exceptional and powerful fusion of search and strategic services. Our clients greatly appreciate the regional and global reach we provide them while still balancing a finely tuned proficiency that is completely dedicated to and driven by their needs, their niche markets. Our values and vision are also a strong component to helping our clients succeed. We strive to have the highest level of integrity and work ethic. Our commitment is to excellence. Our best-in-class performance is unparalleled.
Blaise Group International has an empowering corporate culture that creatively provides the precise solutions our clients need for both their near-term and long-term goals. We are building on our history of success by continually looking after the best interests of our clients, who we view as our partners. We have a vested interest in their success both corporately and individually and look forward to nurturing long-standing relationships with them.
We are also focused on cultivating long-standing relationships with Life Science’s top business professionals, executives, scientists and doctors. We work with many of the absolute best, tried and true leaders and pioneers across all disciplines within Life Sciences. Our candidates have a solid track record of success. Our candidates, past, present and future, are the within the top percentile of their field.
We have been very fortunate to have a vantage point to observe leadership and management trends for many years. The common denominator remains consistent. The measure of success of any organization is achieved only by the quality of their leadership. Therefore we keep a close watch for the next generation leaders. We identify them and help develop them. These are tomorrow’s market makers and pioneers.
From presenting our clients with the absolute best candidates that will make the biggest positive impact, to helping develop leaders to reach their fullest potential, to providing our clients with dynamic business development opportunities or other human capital solutions, we are committed to your success.Blaise Group International has a values-driven tradition of excellence. We look forward to partnering with you. We look forward to your success.
Working together, partnering together. We are leaders in this Life Science driven revolution.
Best wishes and much success,
Stephen M. Ritoch
Stephen M. Ritoch
Chairman / CEO
Stephen M. Ritoch is the Chairman of the Board and Chief Executive Officer of Blaise Group International, Inc. (BGI), a leading retained human capital search and strategic services firm exclusively servicing Life Science organizations on a global basis.
Mr. Ritoch has uniquely structured BGI’s executive through board level search divisions into three niche market categories: Cell & Gene Technologies, Regenerative Medicine and Medical Device. Many of BGI’s clients are some of the world’s largest and well-known pharmaceutical and medical device companies, prestigious academic and not-for-profit organizations, middle market and emerging biotechnology, pure-play device and diagnostic companies.
Two years after the company’s inception Mr. Ritoch formed BGI’s strategic services division that further supports its clients by offering truly value added business development opportunities and organizational development solutions.
Mr. Ritoch has been an early technology enabler and pioneer within Life Sciences, Internet, and enterprise-wide technology solutions serving on the Board of Directors for MyPage, Inc. The first ever guaranteed safe and family appropriate Internet community, a hybrid of the World Wide Web and traditional “brick and mortar” retailing. Mr. Ritoch was also a member of the Board of Directors for Sports Zombie, a collaborative technology solution with a secondary focus for network television targeting amateur sport enthusiasts with a strong emphasis on athletic and sport health wellness. Additionally, Mr. Ritoch served on the Board of Directors of Craft Products.com, the “first-to-market” industry specific auction house, selling online B2B (business to business) to Fortune 1000 corporations and professionals.
Prior to co-founding BGI, Mr. Ritoch served on the senior executive search team of Lucas Group, a national executive search firm founded in 1970. Mr. Ritoch helped the company obtain a much larger market-share position for a desired future IPO (Initial Public Offering). Before Mr. Ritoch’s tenure with Lucas Group, he was an operations and business development specialist with a focus on growth strategies, corporate partnering, talent acquisition, human resource and organizational development. He served in many high profile capacities with a variety of domestic and multi-national companies.
Mr. Ritoch has been a serial entrepreneur with two prior successful start-up companies. The divestiture of these companies brought great value and a tremendous return-on-investment to all shareholders. Mr. Ritoch also is a noteworthy executive advisor and coach to many high profile and influential individuals in senior leadership roles within industry, academia and government institutions. He is also been a significant investor and collaborative partner in several biotechnology and high technology corporations. Mr. Ritoch is an accomplished writer and has been published in the business community, internal corporate enterprises, philosophy and ethics sectors.
- OVERVIEW
-
OVERVIEW
Blaise Group International has emerged to be a leading retained human capital search and strategic services firm exclusively servicing Life Science organizations on a global basis.
This unique fusion of executive through board level search and strategic services has enabled Blaise Group International to partner with a diverse array of organizations. Many clients are considered to be some of the world’s largest and well-known pharmaceutical and medical device companies, prestigious academic and not-for-profit organizations, middle market and emerging biotechnology, pure-play device and diagnostic companies.
Blaise Group International recognizes that each Life Science market sector, every organization, every technology and product carries succinctly different challenges. To best serve its clients, Blaise Group International established the following executive through board level niche market recruiting divisions:
This niche market organizational structure is quite unique to the human capital industry and has proven to be a very effective tool and a major competitive advantage. Each search division has unparalleled expertise within that industry niche market. Blaise Group International’s core competency is centered on the foundation of truly knowing its client, their needs, their market sector and the top performers and key decision makers thereof. As a direct result, Blaise Group International is able to provide the highest level of service and the very best of human capital solutions in Life Sciences.
-
MARKET
EXPERTISE -
MARKET EXPERTISE
Blaise Group International is positioned to be the preeminent human capital search and strategic services leader for the Life Sciences. Each search division has world-class niche market recruiting expertise, pre-established relationships with the top performers and key decision makers therein, have an excellent understanding of its client’s competitive landscape and a considerable proven track record of success.
- BIOTECHNOLOGY
-
BIOTECHNOLOGY DIVISION
The Biotechnology division encompasses organizations within niche markets that have biologic, synthetic and small molecule pharmaceuticals, therapeutics, molecular diagnostics, delivery system technologies and combination products that cover a diversity of disease and clinical indications.
Improving Treatments
Finding Cures and Saving Lives
- PHARMACEUTICAL
-
PHARMACEUTICAL DIVISION
Blaise Group International’s Pharmaceutical Division encompasses organizations that produce medicinal products. BGI collaborates with proven leaders that have driven and continue to drive ideas from early-stage discovery, through drug development, and into the market. BGI’s Pharmaceutical Division clients have a track record of success with regulatory bodies, i.e. U.S. Food and Drug Administration (FDA), Medicines and Healthcare products Regulatory Agency (MHRA), and the European Medicines Agency (EMA), etc.
Blaise Group International appreciates the complexities and challenges of all things pharma – from prescription therapeutics to prophylactics, orphan drugs and over-the-counter (OTC) consumer products. With over 20 years of high-quality continuity, we support our clients, both large and small, in fulfilling medical innovation, expanding market share, and exceeding the requirements of shareholders, scientists, and mostly, the patients.
Global Reach
- MEDICAL DEVICE
-
MEDICAL DEVICE DIVISION
Blaise Group International’s executive through board level recruiting expertise in this division completely encompasses the full spectrum of the medical device niche market. To include but not limited to partnering with organizations that have implantable, biologic, novel device and combination drug/device technologies that comprise of multiple medical needs and clinical indications.
Building Exceptional Teams
Driving Innovation
- CONTRACT SERVICES
-
CONTRACT SERVICES DIVISION
Blaise Group International’s Contract Service Division supports our clients in maneuvering their competitive landscapes. We help them grow and bring more value to our client’s shareholders and their other investors. With over 20 years of niche focus, BGI has helped life science organizations strategize effectively to meet investor timelines while also establishing policy and ensuring compliance and on-site accountability.
As organizations scale and mature, they must continue to fuel growth and create a sustainable value. We specialize in building and integrating business models that bring out the most out of current enterprise capabilities. Blaise Group International is the global leader in securing partnerships with the most respected professionals in the life sciences field that can, along with due diligence on our end, produce navigable and rewarding ideas within the complex Biotechnological, Pharmaceutical, and Medical Device Divisions.
Working & Partnering Together
We are leaders in this life science revolution
-
LETTER FROM
THE CHAIRMAN -
Thank you for your interest in Blaise Group International. We are a global leader in the Life Science human capital solutions and strategic services industry. We focus on executive through board level search. Our recruiting divisions are uniquely structured by niche market expertise. Our strategic services division assists our clients with very specific corporate business development and organizational development goals.
We have a dynamic, exceptional and powerful fusion of search and strategic services. Our clients greatly appreciate the regional and global reach we provide them while still balancing a finely tuned proficiency that is completely dedicated to and driven by their needs, their niche markets. Our values and vision are also a strong component to helping our clients succeed. We strive to have the highest level of integrity and work ethic. Our commitment is to excellence. Our best-in-class performance is unparalleled.
Blaise Group International has an empowering corporate culture that creatively provides the precise solutions our clients need for both their near-term and long-term goals. We are building on our history of success by continually looking after the best interests of our clients, who we view as our partners. We have a vested interest in their success both corporately and individually and look forward to nurturing long-standing relationships with them.
We are also focused on cultivating long-standing relationships with Life Science’s top business professionals, executives, scientists and doctors. We work with many of the absolute best, tried and true leaders and pioneers across all disciplines within Life Sciences. Our candidates have a solid track record of success. Our candidates, past, present and future, are the within the top percentile of their field.
We have been very fortunate to have a vantage point to observe leadership and management trends for many years. The common denominator remains consistent. The measure of success of any organization is achieved only by the quality of their leadership. Therefore we keep a close watch for the next generation leaders. We identify them and help develop them. These are tomorrow’s market makers and pioneers.
From presenting our clients with the absolute best candidates that will make the biggest positive impact, to helping develop leaders to reach their fullest potential, to providing our clients with dynamic business development opportunities or other human capital solutions, we are committed to your success.Blaise Group International has a values-driven tradition of excellence. We look forward to partnering with you. We look forward to your success.
Working together, partnering together. We are leaders in this Life Science driven revolution.
Best wishes and much success,
Stephen M. Ritoch
Stephen M. Ritoch
Chairman / CEOStephen M. Ritoch is the Chairman of the Board and Chief Executive Officer of Blaise Group International, Inc. (BGI), a leading retained human capital search and strategic services firm exclusively servicing Life Science organizations on a global basis.
Mr. Ritoch has uniquely structured BGI’s executive through board level search divisions into three niche market categories: Cell & Gene Technologies, Regenerative Medicine and Medical Device. Many of BGI’s clients are some of the world’s largest and well-known pharmaceutical and medical device companies, prestigious academic and not-for-profit organizations, middle market and emerging biotechnology, pure-play device and diagnostic companies.
Two years after the company’s inception Mr. Ritoch formed BGI’s strategic services division that further supports its clients by offering truly value added business development opportunities and organizational development solutions.
Mr. Ritoch has been an early technology enabler and pioneer within Life Sciences, Internet, and enterprise-wide technology solutions serving on the Board of Directors for MyPage, Inc. The first ever guaranteed safe and family appropriate Internet community, a hybrid of the World Wide Web and traditional “brick and mortar” retailing. Mr. Ritoch was also a member of the Board of Directors for Sports Zombie, a collaborative technology solution with a secondary focus for network television targeting amateur sport enthusiasts with a strong emphasis on athletic and sport health wellness. Additionally, Mr. Ritoch served on the Board of Directors of Craft Products.com, the “first-to-market” industry specific auction house, selling online B2B (business to business) to Fortune 1000 corporations and professionals.
Prior to co-founding BGI, Mr. Ritoch served on the senior executive search team of Lucas Group, a national executive search firm founded in 1970. Mr. Ritoch helped the company obtain a much larger market-share position for a desired future IPO (Initial Public Offering). Before Mr. Ritoch’s tenure with Lucas Group, he was an operations and business development specialist with a focus on growth strategies, corporate partnering, talent acquisition, human resource and organizational development. He served in many high profile capacities with a variety of domestic and multi-national companies.
Mr. Ritoch has been a serial entrepreneur with two prior successful start-up companies. The divestiture of these companies brought great value and a tremendous return-on-investment to all shareholders. Mr. Ritoch also is a noteworthy executive advisor and coach to many high profile and influential individuals in senior leadership roles within industry, academia and government institutions. He is also been a significant investor and collaborative partner in several biotechnology and high technology corporations. Mr. Ritoch is an accomplished writer and has been published in the business community, internal corporate enterprises, philosophy and ethics sectors.